Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer
about
Improved production of recombinant human Fas ligand extracellular domain in Pichia pastoris: yield enhancement using disposable culture-bag and its application to site-specific chemical modifications.Real-time polymerase chain reaction.Effects of vitamin E succinate on the expression of Fas and PCNA proteins in human gastric carcinoma cells and its clinical significance.Live or let die: oestrogen regulation of survival signalling in endocrine response.Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cellsRequirement of inositol 1,4,5-trisphosphate receptors for tumor-mediated lymphocyte apoptosis.Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer.A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer.Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy.Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling.Fas ligand expression and its correlation with apoptosis and proliferation in Lobund-Wistar prostate carcinomas.
P2860
Q35115597-CCCDB2A9-2539-4B3A-9706-2B5377D6BEE1Q35581898-F948FEE1-F4F1-499E-A686-E4094CF2D612Q36474677-8C70EAF5-DE38-4816-86FA-4B847447F79BQ36990808-EADDE0E7-6852-456D-85E5-4DA40D07FDD7Q37401741-A5A2F5C3-DF6C-4BF8-B37F-F98D86BA9B62Q38291229-F1792F79-2604-4A06-93F5-C88E81095F43Q39579728-09DC9E4D-D15F-4E7B-A960-9661F09A68F6Q46799300-D0317E81-01D5-476B-94E1-8760A575C3FBQ47156322-AF748E3E-80C0-4B04-87B4-43CEEF573B05Q47353687-4A723730-7D2C-4F8D-AB91-53F68B60F051Q53798663-683B313E-8CAB-4F58-8647-784B0C8AC844
P2860
Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tumour Fas ligand:Fas ratio gr ...... eceptor positive breast cancer
@ast
Tumour Fas ligand:Fas ratio gr ...... eceptor positive breast cancer
@en
Tumour Fas ligand:Fas ratio gr ...... eceptor positive breast cancer
@nl
type
label
Tumour Fas ligand:Fas ratio gr ...... eceptor positive breast cancer
@ast
Tumour Fas ligand:Fas ratio gr ...... eceptor positive breast cancer
@en
Tumour Fas ligand:Fas ratio gr ...... eceptor positive breast cancer
@nl
prefLabel
Tumour Fas ligand:Fas ratio gr ...... eceptor positive breast cancer
@ast
Tumour Fas ligand:Fas ratio gr ...... eceptor positive breast cancer
@en
Tumour Fas ligand:Fas ratio gr ...... eceptor positive breast cancer
@nl
P2093
P2860
P356
P1476
Tumour Fas ligand:Fas ratio gr ...... eceptor positive breast cancer
@en
P2093
Bernd Gerber
Dirk Koczan
Hans-Jürgen Thiesen
Heiner Müller
Klaus Friese
Toralf Reimer
P2860
P2888
P356
10.1186/BCR456
P407
P577
2002-06-21T00:00:00Z
P5875
P6179
1043698168